If a medication like Wegovy or Zepbound isn't on your formulary at all, getting Aetna to pay for it is an uphill, often impossible, battle
Triple Agonists: These target GLP-1, GIP, and glucagon pathways
Patients treated with GLP-1 agonists often experience transformative health improvements: better diabetes control without the burden of hypoglycemia, significant weight reduction that improves mobility and self-esteem, and a newfound optimism about their health trajectory
In a double-blind, placebo-controlled study in which blood GSH was measured in healthy subjects at several stages, 500 mg of vitamin C taken daily for 2 weeks significantly raised erythrocyte (red blood cell) glutathione levels
Michael Schwartz: GLP-1 and Brain Pathways | Ep